TGFB1 and hepatocellular carcinoma: CYP4F2, a liver enzyme that metabolizes fatty acids, vitamin D, and carcinogens which is expressed at relatively low levels in HCC [24], was found to be negatively associated with TGF-β signaling (Figure 3(b)).